Corporate / CVC · 3 deals
Subsidiary of Singapore-based Ultragreen.ai
Every published round Renew Pharmaceuticals took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| FerronovaPrecision cancer treatment technology | Series A | 17 Dec 2025 | $6m | Lead | movefm.com.au, ferronova.com.au, Artesian VC portfolio, Artesian VC portfolio | |
| Ferronova | Series A | 17 Dec 2025 | $6m | Lead | Wholesale Investor (29 Jan 2026), Wholesale Investor (16 Jan 2026), Startup Daily (19 Dec 2025), SmartCompany, Biotech Dispatch, Uniseed, Startup Daily (17 Dec 2025), Business News Australia, biospectrumasia.com, South Australian Venture Capital Fund portfolio | |
| Ferronova | Series A | 23 Jan 2023 | $8m | Lead | Startup Daily (19 Dec 2025), SmartCompany (19 Dec 2025), Startup Daily (17 Dec 2025), Business News Australia, SmartCompany (23 Jan 2023), Startup Daily (23 Jan 2023) |
Companies Renew Pharmaceuticals has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Ferronova | advance image-guided cancer surgery | 23 Jan 2023, Series A | 2 | 2 |
| FerronovaPrecision cancer treatment technology | 17 Dec 2025, Series A | 1 | 1 |
Fund closes reported for Renew Pharmaceuticals, as distinct from the investments it has made.
Companies Renew Pharmaceuticals has backed that another company then bought. An exit for the holding, not a deal Renew Pharmaceuticals did.
| Name | Role | Sources |
|---|---|---|
| Declan Cassells | COO | Biotech Dispatch, Startup Daily |
Stories naming Renew Pharmaceuticals. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of seven trans-Tasman raises worth $93.1m this week, headlined by IND Technology's $50m round, with LawVu also acquiring ClauseBase.
Adelaide medtech Ferronova has banked another $6 million from returning backers to advance its surgical tracer for cancer, lifting Series A funding to $17.5 million; backer parent UltraGreen.ai floated in Singapore this month.
Also movefm.com.au
Adelaide biotech Ferronova added $6 million to its Series A from prior backers, lifting the round's total to $17.5 million; backer Renew's parent Ultragreen.ai floated in Singapore this month.
Also ferronova.com.au·movefm.com.au·Biotech Dispatch·Startup Daily
Adelaide cancer-focused biotech Ferronova has secured fresh backing: an investor round led by Irish strategic partner Renew Pharmaceuticals plus a federal research grant, to speed clinical trials in stomach and brain cancers.
Also SmartCompany·SmartCompany·Startup Daily·Business News Australia·Startup Daily